cagrilintide vs semaglutide Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes Cagrilintide side effects: what the

Description

A Chronic Metabolic Condition Obesity is traditionally defined as an excess of body fat, and is classically categorized in clinical practice in terms of body mass index (BMI)

GLP-1 medications do reduce appetite, but they also slow stomach emptying, improve fullness signaling, and help regulate blood sugar by affecting insulin and glucagon pathways

J Prescribing Pract

Clinicians should review all medications, as semaglutide's effect on gastric emptying may affect the absorption of oral medications, particularly those with a narrow therapeutic index

Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure